Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000935
Chunk: 26

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 26
---
 requisite corporate power and authority to enter into and (subject to any applicable
rules and regulations of the Principal Market) perform its obligations under this Agreement, the Registration Rights Agreement and each
of the other Transaction Documents, and to issue the Securities in accordance with the terms hereof, (ii) the execution and delivery of
the Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby, including without
limitation, if applicable, the allotment of the Commitment Shares (as defined below in ) and the Purchase Shares issuable
under this Agreement, have been duly authorized by the Company’s Board of Directors (the “”)
and no further consent or authorization is required by the Company, its Board of Directors or its shareholders (except as provided in
this Agreement), (iii) each of this Agreement and the Registration Rights Agreement has been, and each other Transaction Document shall
be on the Commencement Date, duly executed and delivered by the Company and (iv) each of this Agreement and the Registration Rights Agreement
constitutes, and each other Transaction Document upon its execution on behalf of the Company, shall constitute, assuming the due authorization,
execution and delivery of the other party thereto, the valid and binding obligations of the Company enforceable against the Company in
accordance with their terms, except as such enforceability may be limited by (i) general principles of equity or applicable bankruptcy,
insolvency, reorganization, moratorium, liquidation or other laws relating to, or affecting generally, the enforcement of creditors’
rights and remedies, (ii) laws relating to the availability of specific performance, injunctive relief or other equitable remedies and
(iii) insofar as indemnification and contribution provisions may be limited by applicable law. The Board of Directors, or any committee
thereof, has approved the resolutions (the “”) substantially in the form provided to the Investor
to authorize this Agreement, the Registration Rights Agreement and the transactions contemplated hereby and thereby. The Signing Resolutions
are valid, in full force and effect and have not been modified or supplemented in any respect. The Company has delivered to the Investor
a true and correct copy of minutes of a meeting of the Board of Directors, or any committee thereof, at which the Signing Resolutions
were duly adopted by the Board of Directors or a unanimous written consent adopting the Signing Resolutions executed by all of the members
of the Board of Directors or any committee thereof. Except as set forth in this Agreement